Table 3 Summary of skeleton-derived factors acting on vasculature
From: Skeleton-vasculature chain reaction: a novel insight into the mystery of homeostasis
Factors | Sources | Targets | Effects | Mechanisms | References |
---|---|---|---|---|---|
OCN | • Osteoblast | • Endothelial cell | • Protect vascular endothelial cell functions • Prevent atherosclerosis progression | • Upregulate NO and NF-кB signals • Stimulate PI3K/Akt/eNOS pathway | |
PDGF-BB | • Preosteoclast | • Endothelial progenitor cell • Mesenchymal stem cell | • Enhance capillary abundance • Stabilize tube formation • Mediate osteoblast differentiation | • Trigger PI3K/Akt signaling cascade | |
SLIT3 | • Osteoblast | • Endothelial cell | • Promote tube formation and angiogenesis • Help bone remodeling and fracture repair | • Activate ERK mitogen-activated protein kinase and Hippo signaling pathway | |
VEGF | • Osteoblast • Chondrocyte | • Endothelial cell • Osteoprogenitor | • Promote angiogenesis process • Modulate bone development and homeostasis | • Induced by hypoxia via HIF-dependent pathway • Promote induction of β-catenin and activate Wnt signaling pathway | |
FGF | • Osteoblast • Chondrocyte | • Endothelial cell | • Promote angiogenesis process • Elevate vessel permeability | • Induce EC proliferation, chemotaxis, and intercellular gap-junction communication | |
MMP | • Osteoclast • Osteoblast • Chondrocyte | • Endothelial cell | • Contribute to vascular lumen formation | • Via ERK, AKT, or PI3K and SRC pathways • Release angiogenic factors (VEGF, etc.) from matrix | |
LCN-2 | • Osteoblast • Adipocyte | • Endothelial cell | • Make for proper endothelial function • Involved in cardiovascular progression | • Potentiated via IL-1β mediated pathway |